COLIPI


Protocolnummer:

Ziekenhuizen:
Universitair Medisch Centrum Groningen

Titel:
Identification of predictive parameters for colitis in melanoma patients treated with ipilimumab

Behandeling:

Stadium:
Stadium irresectable IIIc/IV

Belangrijkste in/exclusiecriteria:
In: patients with metastatic melanoma who will be treated with ipilimumab. Ex: pre-existing colitis

Contactpersoon:
Geke Hospers

Alle trials